```html

Zygomatic (Cheek) Cellulitis – A Comprehensive Medical Guide

Overview

Zygomatic cellulitis, more commonly called cheek cellulitis, is an acute bacterial infection of the soft tissue that lies over the zygomatic (cheek) bone. The infection typically spreads through the dermis and subcutaneous fat, causing redness, swelling, warmth, and pain. While cellulitis can affect any skin surface, involvement of the cheek region is noteworthy because of its proximity to the eye, nasal passages, and oral cavity, which can facilitate rapid spread to deeper facial structures.

Who it affects: The condition occurs most often in children and adolescents (especially ages 5‑15) but can affect adults of any age. Individuals with compromised immune systems, diabetes, or chronic skin conditions are at higher risk.

Prevalence: Skin and soft‑tissue infections account for roughly 1.5 % of all emergency‑department visits in the United States each year. Cheek cellulitis makes up an estimated 5‑10 % of facial cellulitis cases, translating to several hundred thousand cases worldwide annually [1][2].

Symptoms

Symptoms usually develop over 12‑48 hours after the inciting event (e.g., a small cut or insect bite). The classic triad includes redness, swelling, and pain, but many patients experience additional signs:

• Localized erythema: Redness that sharply demarcates the cheek area, often extending toward the nasolabial fold.
• Swelling (edema): The cheek may feel firm or “boggy.”
• Pain or tenderness: Discomfort that worsens with movement or pressure.
• Heat: The affected skin feels warmer than surrounding tissue.
• Fever: Body temperature ≥ 38 °C (100.4 °F) in up to 40 % of cases.
• General malaise: Fatigue, chills, or feeling “ill.”
• Skin changes: In severe infection, the redness may become violaceous or develop superficial blisters.
• Lymphadenopathy: Tender swollen lymph nodes in the pre‑auricular or submandibular region.
• Restricted mouth opening: “Trismus” can occur if the infection spreads toward the masseter muscle.
• Visual disturbances: Rare but concerning; may indicate spread toward the orbit.

Causes and Risk Factors

Microbial Etiology

The majority of facial cellulitis cases, including cheek cellulitis, are caused by gram‑positive cocci:

• Streptococcus pyogenes (Group A Streptococcus) – 40‑60 % of cases.
• Staphylococcus aureus – 30‑40 % (including MRSA in some regions).

Anaerobic bacteria (e.g., Prevotella spp.) and mixed flora are seen when the infection follows dental or sinus disease.

Common Entry Points

• Minor skin breaks – cuts, scratches, insect bites, or surgical wounds.
• Dental infections – periapical abscesses that breach the buccal mucosa.
• Sinusitis – especially maxillary sinus infection that erodes through the bone.
• Trauma – sports injuries or facial fractures.

Risk Factors

• Age < 16 years or > 65 years.
• Chronic skin conditions (eczema, psoriasis).
• Diabetes mellitus or peripheral vascular disease.
• Immunosuppression (HIV, chemotherapy, steroids).
• Obesity – associated with impaired lymphatic drainage.
• Recent facial surgery or cosmetic procedures.
• Living in crowded or unsanitary conditions, which increase bacterial load.

Diagnosis

Diagnosis is primarily clinical, but certain investigations help confirm the etiology and exclude serious complications.

Physical Examination

• Assessment of the size, margins, and temperature of the erythema.
• Palpation for fluctuance (suggests abscess formation).
• Evaluation of cranial nerve function, especially vision and eye movement.
• Inspection of oral cavity and nasal passages for a source.

Laboratory Tests

• Complete blood count (CBC): Often shows leukocytosis with left shift.
• C‑reactive protein (CRP) and erythrotrolin sedimentation rate (ESR): Elevated in most infections; useful for monitoring response.
• Blood cultures: Recommended if the patient is febrile, appears toxic, or has comorbidities.
• Wound culture: Obtained from any drainage or after incision‑and‑drainage to guide antibiotic choice.

Imaging

• Ultrasound: Fast, bedside tool to differentiate cellulitis from an abscess.
• Contrast‑enhanced CT scan: Indicated when orbital involvement, deep neck space infection, or bone involvement is suspected.
• MRI: Superior for soft‑tissue detail; used in complex or refractory cases.

Diagnostic Criteria (summary)

1. Localized erythema, warmth, swelling, and pain over the cheek.
2. Evidence of systemic inflammation (fever, elevated WBC/CRP).
3. Exclusion of abscess or deeper infection via imaging when indicated.
4. Identification of a bacterial pathogen when cultures are obtained.

Treatment Options

Empiric Antibiotic Therapy

Prompt oral or intravenous antibiotics are essential. Choice depends on severity, local resistance patterns, and patient factors.

Clinical Scenario	First‑Line Oral	First‑Line IV	Comments
Mild‑moderate infection, no MRSA risk	Amoxicillin‑clavulanate 875/125 mg PO q12h	—	Covers Streptococcus & MSSA.
Mild‑moderate with MRSA risk (e.g., recent skin infection, community‑associated MRSA prevalence >10 %)	Clindamycin 300 mg PO q6h OR TMP‑SMX + amoxicillin‑clavulanate	—	Clindamycin also suppresses toxin production.
Severe infection, systemic signs, or immunocompromised	—	IV Cefazolin 2 g q8h + Vancomycin (dose‑adjusted) OR IV Piperacillin‑tazobactam + Vancomycin	Broad coverage; de‑escalate based on cultures.

Therapy is usually continued for 7‑10 days, extending to 14 days if an abscess was drained or if the patient is immunocompromised.

Surgical Management

• Incision and drainage (I&D): Indicated when fluctuant swelling or an abscess is present. Performed under local anesthesia; samples are sent for culture.
• Debridement: Rare in cellulitis but may be required for necrotizing fasciitis (a surgical emergency).

Adjunctive Measures

• Analgesia: Acetaminophen or ibuprofen for pain and fever.
• Elevation: Keeping the head of the bed raised 30‑45° reduces edema.
• Warm compresses: 10‑15 minutes, 3‑4 times daily, can improve circulation.
• Hydration: Adequate fluid intake supports immune function.

Special Populations

• Pregnancy: Prefer beta‑lactams (e.g., ampicillin‑sulbactam). Avoid tetracyclines and fluoroquinolones.
• Pediatrics: Doses based on weight; clindamycin or amoxicillin‑clavulanate are common first‑line agents.
• Diabetes: Tight glucose control improves outcomes; consider broader coverage for gram‑negative organisms.

Living with Zygomatic (Cheek) Cellulitis

Daily Management Tips

1. Medication adherence: Finish the entire antibiotic course, even if symptoms improve.
2. Wound care: Keep any open area clean with gentle soap and sterile gauze; change dressings daily.
3. Monitor temperature: Record twice daily; seek care if fever rises above 38.5 °C (101.3 °F) or persists.
4. Rest and nutrition: Aim for 7‑9 hours sleep; consume protein‑rich foods to support tissue repair.
5. Avoid irritants: Skip spicy foods, alcohol, and tobacco until fully healed.
6. Facial hygiene: Use a mild, fragrance‑free cleanser; avoid scrubbing the affected area.
7. Follow‑up appointments: Typically within 48‑72 hours after starting antibiotics, then weekly until resolution.

Psychosocial Considerations

Facial swelling can affect self‑esteem. Encourage patients to discuss concerns with family or a counselor, and reassure them that most cases resolve without scarring if treated promptly.

Prevention

• Skin protection: Use barrier creams or protective clothing during activities that risk cuts.
• Prompt wound care: Clean any facial laceration or bite immediately with soap and water, then apply an antiseptic.
• Dental health: Regular dental check‑ups; treat cavities or gum disease early.
• Manage chronic conditions: Keep diabetes and immune disorders well‑controlled.
• Vaccinations: Influenza and pneumococcal vaccines reduce secondary bacterial infections.
• Hand hygiene: Wash hands frequently, especially after touching the face.

Complications

If left untreated or inadequately treated, cheek cellulitis can lead to serious sequelae:

• Abscess formation: Requires I&D.
• Orbital cellulitis: Infection spreads to the eye socket – risk of vision loss.
• Deep neck space infection: Can compromise airway; may need surgical drainage.
• Necrotizing fasciitis: Rare but rapidly progressive; high mortality without urgent surgery.
• Septicemia: Systemic spread causing organ dysfunction.
• Scarring or cosmetic deformity: Particularly if ulceration or delayed treatment occurs.

The overall mortality for uncomplicated facial cellulitis is <1 %, but it rises sharply (up to 30 %) when complications such as necrotizing fasciitis or orbital involvement develop [3][4].

When to Seek Emergency Care

---

[1] Centers for Disease Control and Prevention. “Skin and Soft Tissue Infections.” Updated 2023.
[2] Mayo Clinic. “Cellulitis.” Accessed June 2026.
[3] Stevens DL, et al. “Management of Necrotizing Soft Tissue Infections.” *Clin Infect Dis.* 2022;75(4):617‑629.
[4] WHO. “Global Burden of Bacterial Skin Infections.” 2022 report.

```